Nicotinic and opioid receptor interactions in nicotine addiction.
暂无分享,去创建一个
[1] L. Role,et al. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. , 1995, Annual review of physiology.
[2] R. Brooner,et al. Smoking habits and attitudes in a methadone maintenance treatment population. , 1997, Drug and alcohol dependence.
[3] H. Mansvelder,et al. Synaptic Mechanisms Underlie Nicotine-Induced Excitability of Brain Reward Areas , 2002, Neuron.
[4] J T Williams,et al. Cellular and synaptic adaptations mediating opioid dependence. , 2001, Physiological reviews.
[5] R. Maldonado,et al. Involvement of the opioid system in the anxiolytic-like effects induced by Δ9-tetrahydrocannabinol , 2002, Psychopharmacology.
[6] J. Blendy,et al. μ-Opioid Receptor and CREB Activation Are Required for Nicotine Reward , 2005, Neuron.
[7] S. Consolo,et al. Chronic morphine induces long-lasting changes in acetylcholine release in rat nucleus accumbens core and shell: an in vivo microdialysis study , 1999, Psychopharmacology.
[8] C. Lerman,et al. The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial , 2004, The Pharmacogenomics Journal.
[9] John T. Williams,et al. Nicotine activates and desensitizes midbrain dopamine neurons , 1997, Nature.
[10] Nicolas Le Novère,et al. Subunit Composition of Functional Nicotinic Receptors in Dopaminergic Neurons Investigated with Knock-Out Mice , 2003, The Journal of Neuroscience.
[11] H. Mansvelder,et al. Short‐ and Long‐Term Modulation of Synaptic Inputs to Brain Reward Areas by Nicotine , 2003, Annals of the New York Academy of Sciences.
[12] G. Rebec,et al. Impulse activity of ventral tegmental area neurons during heroin self-administration in rats , 2001, Neuroscience.
[13] R. Wise,et al. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. , 1993, The Journal of pharmacology and experimental therapeutics.
[14] G. Koob. Hedonic Homeostatic Dysregulation as a Driver of Drug-Seeking Behavior. , 2008, Drug discovery today. Disease models.
[15] D. Sulzer,et al. Frequency-dependent modulation of dopamine release by nicotine , 2004, Nature Neuroscience.
[16] R. Wise,et al. The neurobiology of addiction , 2019, Annals of the New York Academy of Sciences.
[17] M. E. Wewers,et al. The effect of chronic administration of nicotine on antinociception, opioid receptor binding and met-enkelphalin levels in rats , 1999, Brain Research.
[18] A. Houdi,et al. Nicotine protects against μ-opioid receptor antagonism by β-funaltrexamine: Evidence for nicotine-induced release of endogenous opioids in brain , 1990, Neuroscience Letters.
[19] J. Changeux,et al. Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine , 1998, Nature.
[20] V. Pickel,et al. Major coexpression of κ‐opioid receptors and the dopamine transporter in nucleus accumbens axonal profiles , 2001, Synapse.
[21] E. Nestler,et al. Molecular basis of long-term plasticity underlying addiction , 2001, Nature Reviews Neuroscience.
[22] S. Erhardt,et al. Excitatory and inhibitory responses of dopamine neurons in the ventral tegmental area to nicotine , 2002, Synapse.
[23] A. C. Collins,et al. Characterization of nicotinic agonist-induced [(3)H]dopamine release from synaptosomes prepared from four mouse brain regions. , 2002, The Journal of pharmacology and experimental therapeutics.
[24] H. Mansvelder,et al. Long-Term Potentiation of Excitatory Inputs to Brain Reward Areas by Nicotine , 2000, Neuron.
[25] A. Kuryatov,et al. Nicotine Acts as a Pharmacological Chaperone to Up-Regulate Human α4β2 Acetylcholine Receptors , 2005, Molecular Pharmacology.
[26] N. Chaudhri,et al. Environmental stimuli promote the acquisition of nicotine self-administration in rats , 2002, Psychopharmacology.
[27] P. Lapchak,et al. Regulation of endogenous acetylcholine release from mammalian brain slices by opiate receptors: Hippocampus, striatum and cerebral cortex of guinea-pig and rat , 1989, Neuroscience.
[28] G. A. Tejwani,et al. Preproenkephalin mRNA and Methionine‐Enkephalin Content Are Increased in Mouse Striatum After Treatment with Nicotine , 1995, Journal of neurochemistry.
[29] G. Aston-Jones,et al. Nicotinic effects on the firing pattern of midbrain dopamine neurons. , 1986, Acta physiologica Scandinavica.
[30] A. Adachi,et al. In vivo microdialysis studies of pineal and ocular melatonin rhythms in birds. , 1997, Biological signals.
[31] D. Bertrand,et al. Chronic Nicotine Exposure Upregulates Nicotinic Receptors by a Novel Mechanism , 2005, The Journal of Neuroscience.
[32] H. Mansvelder,et al. Cellular and synaptic mechanisms of nicotine addiction. , 2002, Journal of neurobiology.
[33] G. Aghajanian,et al. Molecular and cellular basis of addiction. , 1997, Science.
[34] J. A. Dani,et al. Roles of dopamine signaling in nicotine addiction , 2003, Molecular Psychiatry.
[35] A. C. Collins,et al. Nicotine Activation of α4* Receptors: Sufficient for Reward, Tolerance, and Sensitization , 2004, Science.
[36] John A. Dani,et al. Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum , 2001, Nature Neuroscience.
[37] Michele Zoli,et al. Molecular and Physiological Diversity of Nicotinic Acetylcholine Receptors in the Midbrain Dopaminergic Nuclei , 2001, The Journal of Neuroscience.
[38] D. Grandy,et al. Vesicular Dopamine Release Elicits an Inhibitory Postsynaptic Current in Midbrain Dopamine Neurons , 2004, Neuron.
[39] J E Smith,et al. The effects of intravenous heroin administration on extracellular nucleus accumbens dopamine concentrations as determined by in vivo microdialysis. , 1995, The Journal of pharmacology and experimental therapeutics.
[40] M. Picciotto,et al. Acute and long‐term changes in the mesolimbic dopamine pathway after systemic or local single nicotine injections , 2002, The European journal of neuroscience.
[41] J. Costentin,et al. Involvement of cholinergic neurons in the release of dopamine elicited by stimulation of μ-opioid receptors in striatum , 1997, Brain Research.
[42] C. Jepson,et al. Association of OPRM1 A118G variant with the relative reinforcing value of nicotine , 2006, Psychopharmacology.
[43] C. Nicholson,et al. Dopamine-mediated volume transmission in midbrain is regulated by distinct extracellular geometry and uptake. , 2001, Journal of neurophysiology.
[44] N. Koshikawa,et al. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens , 2005, Neuroscience.
[45] B. Hoebel,et al. Morphine and naloxone, IP or locally, affect extracellular acetylcholine in the accumbens and prefrontal cortex , 1996, Pharmacology Biochemistry and Behavior.
[46] P. Sargent,et al. The diversity of neuronal nicotinic acetylcholine receptors. , 1993, Annual review of neuroscience.
[47] W. Corrigall,et al. Evidence for opioid mechanisms in the behavioral effects of nicotine , 2006, Psychopharmacology.
[48] John T. Williams,et al. Properties and Opioid Inhibition of Mesolimbic Dopamine Neurons Vary according to Target Location , 2006, The Journal of Neuroscience.
[49] K. Richter,et al. Tobacco use and quit attempts among methadone maintenance clients. , 2001, American journal of public health.
[50] S. Cragg,et al. Nicotine amplifies reward-related dopamine signals in striatum , 2004, Nature Neuroscience.
[51] E. Albuquerque,et al. Nicotinic Receptor Subtypes in Rat Hippocampal Slices Are Differentially Sensitive to Desensitization and Early in Vivo Functional Up-Regulation by Nicotine and to Block by Bupropion , 2005, Journal of Pharmacology and Experimental Therapeutics.
[52] G F Koob,et al. Drug abuse: hedonic homeostatic dysregulation. , 1997, Science.
[53] D. Bertrand,et al. Chronic Exposure to Nicotine Upregulates the Human α4β2 Nicotinic Acetylcholine Receptor Function , 2001, The Journal of Neuroscience.